Clinical Trial Update: Nimotuzumab in Children With Intrinsic Pontine Glioma

View source ↗

Summary

This clinical trial update notes the completion of a study evaluating nimotuzumab in pediatric patients with diffuse intrinsic pontine glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Oncoscience AG | Conditions: Diffuse Instrinsic Ponitine Glioma | Status: COMPLETED